APA (7th ed.) Citation

Ohtsuka, Y., Yoshinaga, H., Shirasaka, Y., Takayama, R., Takano, H., & Iyoda, K. (2016). Long-term safety and seizure outcome in Japanese patients with Lennox–Gastaut syndrome receiving adjunctive rufinamide therapy: An open-label study following a randomized clinical trial. Epilepsy research, 121, 1-7. https://doi.org/10.1016/j.eplepsyres.2016.01.002

Chicago Style (17th ed.) Citation

Ohtsuka, Yoko, Harumi Yoshinaga, Yukiyoshi Shirasaka, Rumiko Takayama, Hiroki Takano, and Kuniaki Iyoda. "Long-term Safety and Seizure Outcome in Japanese Patients with Lennox–Gastaut Syndrome Receiving Adjunctive Rufinamide Therapy: An Open-label Study Following a Randomized Clinical Trial." Epilepsy Research 121 (2016): 1-7. https://doi.org/10.1016/j.eplepsyres.2016.01.002.

MLA (9th ed.) Citation

Ohtsuka, Yoko, et al. "Long-term Safety and Seizure Outcome in Japanese Patients with Lennox–Gastaut Syndrome Receiving Adjunctive Rufinamide Therapy: An Open-label Study Following a Randomized Clinical Trial." Epilepsy Research, vol. 121, 2016, pp. 1-7, https://doi.org/10.1016/j.eplepsyres.2016.01.002.